InMode Ltd vs MiniMed Group Inc. Common Stock — how do they compare? InMode Ltd trades at $14.22 (market cap $809.93M), while MiniMed Group Inc. Common Stock trades at $19.66 (market cap $5.57B). The key difference: MiniMed Group Inc. Common Stock is far larger — about 6.9× InMode Ltd's market cap, and MiniMed Group Inc. Common Stock is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and MiniMed Group Inc. Common Stock for 1 Days on average.
| INMD | MMED | |
|---|---|---|
Market Cap | $809.93M | $5.57B |
Volume | 365,490 | 23,336,073 |
Sector | Health | Health |
52-Week High | $16.62 | $23.84 |
52-Week Low | $12.76 | $10.80 |
Typical Hold Time | 28 Days | 1 Days |
Enterprise Value | $313.27M | $5.37B |
Signals from Pluang's Aura AI — not financial advice
InMode (INMD) trades at $14.21, up 1.43% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with a P/E of 11.63, gross margins of 76.52%, and consistent profitability. Recent Q2 2026 earnings beat expectations with $95.6M revenue, while facing shareholder activism from Steel Partners' $16.75 per share acquisition offer.
Investment outlook remains cautious with analyst consensus divided (45% Buy, 55% Hold) amid cyclical industry softness. Key opportunities include international growth and new product launches like Morpheus8 Cool, while risks involve US sales declines and capital allocation concerns. The stock presents value characteristics but requires monitoring of management's strategic response to acquisition pressure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →